Browse 15 News Items
News
Recommendations to Senate Committee About Pharmacare
Diabetes Canada appeared before Senate Committee to present recommendations about Bill C-64, An Act respecting pharmacare.
September 25, 2024
News
Notice of Baqsimi (Glucagon Nasal Powder) shortage and recommended care adjustments
By Denise Barnard
January 21, 2025
News
A Joint Response to Bill C-64, An Act Respecting Pharmacare, Receiving Royal Assent from Diabetes Canada and JDRF Canada
For the more than four million people living with diabetes in Canada, access to affordable medications is critical. As Bill C-64, An Act Respecting Pharmacare, received Royal Assent, we applaud the Government of Canada for taking the initial steps towards the development of a plan to provide coverage for a range of diabetes medications. However, many of the concerns brought forth by both Diabetes Canada and JDRF Canada remain unanswered.
October 11, 2024
News
Notice of Baqsimi (Glucagon Nasal Powder) Shortage and Recommended Care Adjustments
January 21, 2025
News
Ontario’s New Drug Policy Requires Switching from Biologic Drug to A Biosimilar Insulin
January 30, 2023
News
Update: Supply of glucagon remains secured for Canadian use
Diabetes Canada has received inquiries in recent months from concerned individuals who have not been able to find injectable glucagon products, critical for many who depend on it for the treatment of low blood sugar (hypoglycemia). Health Canada has also updated us that they continue to work with Amphastar to ensure continued Glucagon Injection access in Canada.
October 15, 2024